All Stories

  1. Healthcare Cost Associated with an Acute Mental Healthcare Bundle in Pediatric Emergency Departments
  2. Travel Distance and Its Impact on Wait Time for Positron Emission Tomography–Computed Tomography in Patients with Cancers
  3. Travel Distance and Its Impact on Wait Time for Positron Emission Tomography–Computed Tomography in Patients with Cancers
  4. Healthcare resource use and costs associated with extreme heat in Alberta, Canada
  5. Length of Stay and Home Discharge for Patients with Inpatient Stroke Rehabilitation
  6. The Healthcare Cost Burden in Adults with High Risk for Cardiovascular Disease
  7. Outcome and Cost of Optimal Control of Dyslipidemia in Adults With High Risk for Cardiovascular Disease
  8. Lack of benefit from hospitalization in patients with syncope: A propensity analysis
  9. Assessment of Costs of Avoidable Delays in Intensive Care Unit Discharge
  10. The Current and Future Hospitalization Cost Burden of Syncope in Canada
  11. A Population-Based Study Evaluating Sex Differences in Patients Presenting to Emergency Departments With Syncope
  12. Temporal Trends Of Pharmacologic Therapies For Patients With Chronic Obstructive Pulmonary Disease In Alberta, Canada
  13. The Costs of Industry-Sponsored Drug Trials in Canada
  14. Publicly funded clinical research in Canada
  15. Current and future direct healthcare cost burden of chronic obstructive pulmonary disease in Alberta, Canada
  16. Total and Cause-Specific Mortality After Percutaneous Coronary Intervention: Observations From the Alberta Provincial Project for Outcome Assessment in Coronary Heart Disease Registry
  17. A Population-Based Study of Device Eligibility, Use, and Reasons for Nonimplantation in Patients at Heart Function Clinics
  18. Association between strained ICU capacity and healthcare costs in Canada: A population-based cohort study
  19. The Costs of Industry-Sponsored Medical Device Clinical Trials in Alberta
  20. Incremental costs of high intensive care utilisation in patients hospitalised with heart failure
  21. Health Care Resource Utilization Among Children With Congenital Heart Disease: A Population-Based Study
  22. Resource Use and Burden of Hospitalization, Outpatient, Physician, and Drug Costs in Short- and Long-term Care After Acute Myocardial Infarction
  23. The high cost of critical care unit over-utilization for patients with NSTE ACS
  24. A Population-Based Study Evaluating Differences in Admission Rates and Outcomes Between Men and Women Presenting to Emergency Departments with a Primary Diagnosis of Syncope
  25. A Population-Based Study of Syncope in the Young
  26. A Population-Based Cohort Study Evaluating Outcomes and Costs for Syncope Presentations to the Emergency Department
  27. The Economic Contribution of Industry-Sponsored Pharmaceutical Clinical Trials
  28. The Healthcare Cost Burden of Acute Myocardial Infarction in Alberta, Canada
  29. Quality of Acute Myocardial Infarction Care in Canada: A 10-Year Review of 30-Day In-Hospital Mortality and 30-Day Hospital Readmission
  30. RELATIVE BURDEN OF HOSPITALIZATION, OUTPATIENT, PHYSICIAN, AND DRUG COSTS IN THE SHORT- AND LONG-TERM AFTER ACUTE MYOCARDIAL INFARCTION
  31. Assessing physician knowledge regarding indications for a primary prevention implantable defibrillator and potential barriers for referral
  32. Cost of Congenital Heart Disease Hospitalizations in Canada: A Population-Based Study
  33. Temporal Trends of Reperfusion Strategies and Hospital Mortality for Patients With STEMI in Percutaneous Coronary Intervention–Capable Hospitals
  34. Authors’ Reply to Holko: “Forecasting Pharmaceutical Prices for Economic Evaluations When There Is No Market: A Review”
  35. Comment on: “Forecasting Pharmaceutical Prices for Economic Evaluations When There is No Market: A Review”
  36. Forecasting Pharmaceutical Prices for Economic Evaluations When There Is No Market: A Review
  37. The current and future financial burden of hospital admissions for heart failure in Canada: a cost analysis
  38. Cost Effectiveness of Eplerenone for the Treatment of Systolic Heart Failure with Mild Symptoms in Alberta, Canada
  39. Utilization of HIV Voluntary Counseling and Testing in Vietnam: An Evaluation of 5 Years of Routine Program Data for National Response